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PRESIDENTIAL ADDRESS
From the Society for Vascular Surgery
The Society for Vascular Surgery—State of the
Society, 2008
K. Wayne Johnston, MD, FRCS(C), Toronto, Ontario, CanadaDoes the Society for Vascular Surgery (SVS) need to
exist? This is a frank but reasonable question.
A decade ago, many of us took for granted that vascular
surgery was durable and unchanging. The specialty primar-
ily dealt with major open surgery. But then things began to
change.
For many vascular surgeons, the past decade or more
been has insecure and uncertain for a number of reasons.
Many of us were slow to recognize and embrace
the changes that were occurring in our specialty and to
provide comprehensive vascular care, including minimally
invasive and open surgery. It has taken a decade to learn and
practice the new interventional skills and to show our
referring doctors that we are a changed specialty. We are
among the smallest of the specialties and we were divided.
We didn’t always listen well to each other, we didn’t
understand each others’ views, and for a time we didn’t
work together. During this time, cardiologists, interven-
tional radiologists, and cardiothoracic surgeons increas-
ingly began treating vascular diseases.
As a result of these and other factors during the past
decade of change, we began losing our independent iden-
tity as the vascular specialists.
FUTURE TRENDS THAT WILL AFFECT
VASCULAR SURGERY
We live in changing times and our future may still seem
uncertain. What will our future hold? To answer this ques-
tion and develop strategic plans for the SVS, the SVS Board
of Directors met in February 2008. I list five future trends
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decade:
● We will have increased vascular patient numbers be-
cause of the influence of the diabetes–obesity epi-
demic. The number of older people will double as
people live longer and the baby boomers join the age
65 population. Unless we increase the number of
vascular surgeons, there will be too few to meet the
demands for vascular care and other specialties will step
in.
● Patient expectations will be different. Patients from the
baby boomer generation will request earlier treatment,
particularly minimally invasive interventions, to main-
tain their active lifestyles.
● Science and technology trends will mean that future
treatment will be even less invasive because of im-
proved imaging resolution and further miniaturization
of devices. The results of basic science work will con-
tinue to advance the prevention and care of vascular
diseases. New pharmacology will control the rate of
aneurysm dilatation and carotid plaque progression
and will limit restenosis and allow more aggressive
minimally invasive interventions.
● Economic trends related to the United States (US)
health care system will have a negative impact. To address
the high cost of health care, reimbursement for medical
care will continue to decline. Reimbursement for surgical
specialties will continue to fall disproportionately as more
funds are shifted to primary care. The Center for Medi-
care and Medicaid Services (CMS) will attempt to link
payment to outcomes by withholding payment unless
the efficacy of a treatment is documented.
● Legislative trends may also have a negative impact. To
provide better access to health care, one of the models
of universal health care will be introduced. Practice will
be more regulated by emphasizing practice guidelines
and requiring mandatory tracking of outcomes for our
commonly performed procedures.
These future trends will affect the SVS and vascular
surgery.
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I asked the question “Does the SVS need to exist?” The
message in this address is straightforward. Yes, the SVS
does need to exist to address the future trends I just
described and to advance vascular surgery.
To this end, the SVS Board of Directors recommended
three major goals for the Society:
1. To promote the independent identity of vascular sur-
gery.
2. To advance comprehensive vascular care that includes
open and endovascular interventions, vascular labora-
tory diagnosis, imaging, and others.
3. To be the recognized voice for vascular surgeons.
A STRATEGIC PLAN
Creating this statement of our overall goals is merely an
intellectual exercise unless we develop specific objectives
and realistic plans of action to achieve the goals. The SVS
plan for the future brings together the previous work of the
Society and our proposed strategies.
In this address, I will describe our six specific objectives
under the following headings: promoting independent
identity, advancing comprehensive care through education,
research, and training more vascular surgeons, and being a
recognized voice by being an authoritative voice and an
influential voice. For each of these objectives, I will describe
our action plans.
Note that there are other objectives and action plans
that we could have added. However, our budget re-
quired that we choose those that are most likely to meet
our goals.
SVS WILL PROMOTE THE INDEPENDENT
IDENTITY OF VASCULAR SURGERY
The first objective of the SVS plan is to promote the
independent identity of vascular surgery and to ensure that
primary care physicians realize that only vascular surgeons
can provide comprehensive vascular care.
For the past decade, we have had a vigorous debate
about independence of our specialty and how to achieve it.
One year ago, we formed the Vascular Surgery Action
Committee (VSAC), chaired by Jack Cronenwett, and
asked them to recommend optimal methods to promote
independence for the specialty. They concluded that “in-
dependence” of a specialty is determined by two factors: (1)
control of training and certification and (2) ownership of
the identity of being the vascular disease specialists. I will
address these two issues separately.
CONTROL OF TRAINING AND CERTIFICATION
Control of training and certification is a function of
Board and Residency Review Committee status. VSAC
recommended that we negotiate with The American Board
of Surgery (ABS) with the goal of clearly defining vascular
surgery as a separate specialty, independent of general
surgery.In December 2007, Pat Clagett, Jack Cronenwett, and
I met with senior members of ABS leadership. The details
of this meeting and subsequent negotiations were distrib-
uted, and the SVS Board unanimously approved the agree-
ment we negotiated. The essential components of the
agreement with the ABS are the following.
The ABS agreed that “general surgery residents are no
longer trained to treat the full spectrum of arterial vascular
disease, and vascular surgery fellowship training is now
essential for finishing residents who wish to practice in this
area.” And that “future surgeons who wish to practice
comprehensive vascular surgery should complete an accred-
ited vascular fellowship and obtain the vascular surgery
certificate”. The ABS agree to change its bylaws “to for-
mally recognize that the Vascular Surgery Board, chaired
by John Ricotta, has full authority to make all decisions
related to vascular surgery training, certification standards,
and examination development.”
Thus, the first component of independence, having
control of training and certification, is now enshrined in the
Vascular Surgery Board.
Establish ownership of the identity of “vascular
disease” specialists
The second component of independence of our spe-
cialty is to actually have ownership of the identity of being
the vascular disease specialists. Owning identity depends on
having a consistent message. We have three components to
our action plan:
Our message is simple and consistent. Vascular sur-
geons are the only specialists who can offer comprehensive
vascular care, including open and minimally invasive
procedures.
To whom do we target our message? The SVS Com-
munications Committee, chaired by Mickey Meier, com-
missioned two nationwide surveys of primary care doctors
and of patients and concluded that the way to achieve a
better understanding of our specialty was through educa-
tion of primary care physicians. To brand our identity to
patients would have an exorbitant multimillion dollar cost.
How to brand our independent identity. Can the
SVS brand our identity through a national campaign? No.
We can only do it locally. We need the support of the
members of the SVS and the members from the regional
vascular societies to establish a grassroots campaign. Spe-
cifically we need to make our branding effort part of the
everyday practice of every vascular surgeon. Our highly
successful practitioners have reminded us that all “sales
are local,” and the best way to brand the identity of
vascular surgeons is using one-on-one contact. After each
office or clinic visit, I encourage you to use paper, the
telephone, or preferably “face-to-face time” to deliver your
message (which is our message) directly to one of your
primary care doctors. We are the only ones that can provide
comprehensive vascular care.
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CONTINUING EDUCATION
Our members have told the Education Council,
chaired by Peter Lawrence, that one of the very important
objectives for the SVS is to help keep their knowledge
current. Hence, the SVS aims to be the preeminent source
for continuing education on vascular disease by organizing
education programs and publications. I will summarize five
of the many components to our education action plan.
Annual meeting. The structure of our annual meeting
is evolving in response to your requests. This year, the
Annual Meeting Program Committee, chaired by Rich
Cambria has done an outstanding job in expanding the
program and providing new formats that will enhance your
satisfaction of the meeting.
New Continuing Medical Education formats. We
recognize the need to provide your Continuing Medical
Education (CME) opportunities in a format that is most
convenient for you. Tell us what format best suits your busy
schedule: traditional meetings and seminars, DVDs, pod-
casts, or webinars.
Skills training. A decade ago, the SVS recognized the
importance of retraining vascular surgeons to meet the
needs of our changing specialty and organized didactic
lectures, simulator training, and hands on training in endo-
vascular techniques. These efforts have helped reshape our
specialty.
We aim to continue to be sure that practicing vascular
surgeons acquire advanced endovascular skills. With corpo-
rate support, we have developed hands-on training and
mentoring in carotid stenting and lower extremity inter-
ventions under the leadership of Peter Schneider and Sean
Lynden, respectively. Announcements of these programs
are on VascularWeb.
Publications. Our publications are very strong. The
Journal of Vascular Surgery remains the best vascular jour-
nal and one of the leading surgical journals worldwide
under the editorship of Jack Cronenwett and Jim Seeger,
who will be followed next year by the newly appointed
editors, Tony Sidawy and Bruce Perler.
Our newspaper, the Vascular Specialist, under the edi-
torship of George Andros, is popular and distributes our
message of comprehensive care to SVS members and to an
additional 5000 physicians in other specialties.
To be sure that the name Bob Rutherford remains
associated with vascular surgery education, the SVS has
assumed sponsorship of Rutherford’s textbook, which is
currently undergoing revision for publication of its 7th
edition.
VascularWeb is our main portal for communication
with our members and patients and has more than
3,000,000 visits per year. A work group, chaired by Pat
O’Hara, is reviewing its structure and content to be sure
it meets your high expectations. Be sure to direct your
patients and referring doctors to the patient section of
VascularWeb, which contains authoritative information on
vascular diseases, diagnosis, and treatment. Note that thissection is widely cited in MedlinePlus, which is the patient
information site that is provided by the National Library of
Medicine and National Institutes of Health.
Maintenance of Certification. Maintenance of Certi-
fication (MOC) has been mandated by the American Board
of Medical Specialties and is here to stay. Our MOC com-
mittee, chaired by John Ricotta, will assist you to under-
stand and comply with MOC.
In addition to taking a recertification examination ad-
ministered by the Vascular Surgery Board, there are two
additional requirements for MOC: you must accumulate
CME hours and you must participate in self-assessment
activities. To help you meet the requirement for participa-
tion in self-assessment activities, the SVS has two programs.
First, in each issue the JVS there are multiple-choice questions
related to the published articles. Second, an SVS committee,
chaired by Kim Hodgson, has developed the Vascular Educa-
tion and Self-Assessment Program (VESAP), which is similar
to the Surgical Education and Self-Assessment Program
(SESAP) from the American College of Surgeons and will
be available later this summer.
SVS WILL FOSTER RESEARCH THAT WILL
OPTIMIZE PATIENT CARE
The next objective of the SVS is to foster research that
will optimize patient care.
Why support research? Why support research? Our
previous research innovations have improved the care of
patients with vascular disease and helped establish our
ownership of aneurysms, peripheral arterial disease, carotid
disease, and venous disease. Furthermore, over the past
decade, when the independence and existence of our spe-
cialty was in doubt, vascular surgeons have made the major
contributions to endovascular treatment and some of the
most important contributions to the basic science under-
standing of aortic aneurysms and the problem of restenosis
after vascular intervention.1
The SVS has developed several programs with the help
of the Research Council, chaired by Rick Powell, the Re-
search and Education Committee, chaired by Larry Kraiss,
the Outcomes Committee, chaired by Greg Sicard, and the
American Vascular Association (AVA), chaired by Bill
Pearce. I will mention only two of our research action plans.
Importance of the vascular surgical researcher.
Probably the biggest challenge to conducting medical re-
search today is the lack of qualified surgical researchers who
can do the basic science and also can link the results of their
basic science work to clinical practice—so called the trans-
lational research.
As you heard yesterday from Bill Pearce, Chair of the
AVA, for 2008 the AVA Award Program totaled approxi-
mately $900,000. Ron Stoney is President of the Board of
Trustees of The Foundation for Accelerated Vascular Re-
search, formerly called the Pacific Vascular Research Foun-
dation, and provides an annual Wylie Scholar Research
Grant Award in the amount of $150,000.
Because those who innovate dominate, I want to em-
phasize the importance of our fund-raising effort by our
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promote the next generation of translational researchers
and with their new focus to support other SVS programs. If
you have not made an AVA donation, please give.
Vascular registry. The value of the data from the SVS
carotid stenting and endarterectomy registry was shown in
this morning’s paper from the Outcomes Committee. We
plan to expand our registry to include lower extremity,
renal and other areas.
Why have a registry? First, to help establish standards
and improve the care of patients with vascular disease. As
clinicians, this should be our primary goal. Second, to
document the effectiveness of our treatments.
As overall health care costs continue to rise, only effec-
tive treatment will be funded and reimbursed. With the SVS
registry, we have the opportunity to determine the clinical
effectiveness of our procedures in the real-world environ-
ment, including late results and complications.
As I will describe later, we must be a recognized voice in
establishing the effectiveness of our current procedures and
new technologies, and the Registry will help us accomplish
this. Carotid stenting, renal stenting, and lower extremity
revascularization are in the CMS spotlight. Through the
Registry initiative, the SVS and its members have a great
opportunity to help influence Medicare coverage decisions.
SVS WILL FACILITATE TRAINING OF MORE
VASCULAR SURGEONS TO MEET
INCREASING DEMANDS FOR VASCULAR
CARE
An objective of the SVS is to facilitate training of more
vascular surgeons to meet the increasing demands for vas-
cular care in the growing population of elderly patients.
Previously, the SVS leadership recognized the changes that
were occurring in our specialty and created new resident
training paradigms. The 0-5 program allows students to
enter vascular surgery directly from medical school and
gives the trainees more time to learn the skills required to
practice contemporary vascular surgery and spend less time
in training.
I will comment on three components of the SVS action
plan.
Workforce study. None of us is under the illusion that
this it will be easy to expand the number of trainees. First,
we need to justify increasing the number of vascular sur-
geons by carrying out a workforce study. This will be one of
the assignments for the Clinical Practice Council, chaired
by Bruce Perler.
Facilitate developing new training programs and
expanding number of trainees in current programs.
The SVS will aim to expand the number of trainees in
current vascular programs in collaboration with the Asso-
ciation of Program Directors in Vascular Surgery (APDVS)
and their president Joe Mills. Also, an SVS work group
chaired by Joann Lohr will help high-volume and high
quality vascular practices write applications to the Accredi-
tation Council for Graduate Medical Education to create
new vascular surgery fellowship programs.Increase awareness by medical students and resi-
dents and increase recruiting of good people into
training. We must recruit more good students and resi-
dents into training by increasing their awareness of the
multifaceted nature of the specialty. We currently have
good applicants in increasing numbers; however, we cannot
be complacent. We must reach out to medical students and
surgical residents early in their training to be sure that they
are aware of the rewards of our specialty and realize that
vascular surgery gives them flexible training opportunities,
including the 0-5 program, the traditional 5-2 program,
and other options in between.
There are two effective SVS strategies to recruit train-
ees. First, Clem Darling and his committee have provided
55 scholarships this year for medical students and residents
to attend our annual meeting and have organized an excel-
lent program for them. I encourage the regional vascular
surgery societies to do the same. Also, medical students and
residents have a newsletter from the SVS, a section on
VascularWeb, and podcasts. Second, evidence documents
that a major determinant of the career choices of young
doctors is stimulation from mentors. You don’t have to be
in university practice to volunteer to mentor a student. This
year, let’s all agree to mentor one medical student or
resident and show them the excitement that we have expe-
rienced from vascular practice.
SVS WILL BE THE AUTHORITATIVE VOICE
ON VASCULAR DISEASE
An objective of the SVS is to become the authoritative
voice on vascular disease to patients, the medical profes-
sion, regulatory bodies, legislators, and payers.
Institute of Medicine publication
Earlier this year, the Institute for Medicine (IOM) of
the National Academies of Sciences, published a report
entitled “Knowing What Works in Health Care.”2 They
noted that health care costs would be lower if we knew
which health care services were effective and which patients
were most likely to benefit.
Determining effectiveness of treatment is not a new
concept. The IOM proposes to have authoritative bodies
carry out systematic reviews of existing research studies and
develop evidence-based clinical practice guidelines. Contri-
butions by specialty medical societies, like the SVS, will be
very important. At this stage it is unclear how this informa-
tion will be implemented, but the SVS has a trusted rela-
tionship with payers and legislators and is in an excellent
position to provide input on the full spectrum of vascular
treatment.
SVS plans
We are the experts on vascular disease and can demon-
strate our ownership of vascular disease by standardizing
reporting nomenclature, publishing authoritative guide-
lines on what constitutes best practice for the management
of the vascular patient, and actively assessing the effective-
ness of management. The Clinical Practice Council, chaired
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Powell, are coordinating four action plans.
Standardizing reporting nomenclature. Of basic
importance in reporting results and comparing treatments
is using standardized reporting nomenclature. This effort is
chaired by Jim McKinsey.
Practice guidelines. A committee chaired by Enrico
Ascher is writing practice guidelines for the management of
our most common vascular diseases based on the best
available clinical evidence. Our carotid disease and renal
dialysis access guidelines are in press and more will follow.
These guidelines will be a very important basis for judging
effectiveness of treatment.
Registry. I previously mentioned the importance of
our registry in helping us assess the effectiveness of carotid
stenting and carotid endarterectomy and determining the
subgroups of patients that are most likely to benefit. As we
expand the registry to include lower extremity, renal, other
areas, our visibility and respect from regulatory agencies
including CMS will increase further. With your help, the
quality and influence of the Vascular Registry will make us
proud that we created it.
Performance goals for evaluating new technolo-
gy. To evaluate the effectiveness of new treatments, the
Food and Drug Administration (FDA) has encouraged
professional groups to develop performance standards for
typical therapies against which new devices can be evaluated
expeditiously.
The Clinical Research Committee, chaired by Mike
Conte, will establish expected results for treating critical
limb ischemia by analyzing data from existing randomized
clinical trials. The effectiveness of a new device, drug, or
biological for treating lower extremity ischemia can then be
compared to this dataset. From this comparison, the FDA
can determine if the new treatment has met an adequate
level of safety and reasonable efficacy and can approve it for
market promptly.
To some, writing these SVS documents and involve-
ment in assessment of the effectiveness of treatment may
seem to be only of academic interest. However, determin-
ing effectiveness and publishing practice guidelines will
raise the standard of patient care. In addition, the SVS and
vascular surgeons will become the recognized authorities
for best vascular practice. When effectiveness of treatment
becomes a determinant for reimbursement, by continuing
to establish our much-respected relationship with regula-
tory agencies, we will be consulted.
SVS WILL BE AN INFLUENTIAL VOICE TO
CONGRESS AND REGULATORY AGENCIES
The final major objective of the SVS is to continue to be
an influential voice to Congress and regulatory agencies on
vascular health care issues, including reimbursement.
Let me begin by presenting the challenges that physi-
cians face in the current US health care environment, from
a Canadian’s perspective.The health care environment
There is no perfect health care system. Worldwide, the
challenges in health care are threefold—economic, ethical,
and political.3
Economic challenges. At the present time, every na-
tion faces common problems in trying to allocate resources
for health care in a way that is both equitable and efficient.
Indeed, the health care economist Victor Fuchs wrote that
all nations face the question “Who shall live?” Hence, based
on how much money is spent, each nation defines its own
death rate.
Very soon, economic factors in the United States will
mandate major changes in the health care system, including
implementation of a universal health care system. There are
three economic realities. Today, health care accounts for
more than one in every seven dollars spent in the US
economy. The number of Americans without insurance
now is 47 million or 15% of the population. The competi-
tive edge of American industry is being weakened because
industry bears a large burden of health care costs.
Ethical challenges. In my view, inequities in health
care delivery can only be solved if we agree on the ethical
principle that we must be just and fair to all. This can be met
only by having universal health care – specifically, having
access to basic health care for every citizen. History records
that the stability of a society depends upon the extent to
which the members of that society feel that they are being
treated justly. When some of society’s members come to
feel that they are subject to unequal treatment, the foun-
dations have been laid for social unrest.
Political challenges. As the late Dr Michael DeBakey
pointed out to Congress in accepting his Congressional
Medal, the US government has been discussing universal
health care for several decades. But the present environ-
ment is extreme, and I believe that the politicians will soon
have no choice but to guarantee that all people can enroll in
a basic health care package.
I do not think that high-pressure lobby groups can
successfully counter the arguments posed by the current
economic realities of health care and by the principle that
justice and fairness must prevail.
The challenge for every society is to allocate health care
resources as fairly as possible and to do as much good as
possible. As health care resources are reallocated, the SVS
needs to position itself to understand what is happening in
Washington and to represent the interests of vascular sur-
geons and our patients.
What the SVS has done and will do
The SVS is in a strong position to represent your
interests related to reimbursement and coding and federal
regulatory and legislative issues because of the trusted
relationships that members and staff of the Health Policy
Committee, chaired by Bob Zwolak, have established.
Over the years, the group has worked to get approval for
multiple new Current Procedural Terminology codes and
have the Relative Value Update Committee assign them rela-
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geons. To comment on the strength of our Health Policy
group, I will highlight three major accomplishments:
Expense payments. The first realization that we could
have a direct impact in Washington came in 1997. At that
time, SVS faced major reductions in practice expense pay-
ments from Medicare. The SVS convinced a number of key
Senators and Congressmen that under-represented special-
ties at the American Medical Association, such as vascular
surgery, should have the opportunity to submit their sup-
plemental practice expense data for review. SVS was the first
specialty society to submit supplemental data from many
members across the country, and our efforts saved millions
of dollars of lost income.
The Screening Abdominal Aortic Aneurysms Very
Efficiently (SAAAVE) Act. Our second major legisla-
tive victory was passage of the Medicare screening ben-
efit for abdominal aortic aneurysms in 2005. SVS led the
National Aneurysm Alliance, which bought the SAAAVE
Act to reality in one of the fastest times on record to gain
a preventive service benefit for Medicare. Further work is
required on the SAAAVE Act.
Deficit Reduction Act. Our third partial success re-
lates to the Deficit Reduction Act (DRA), which was passed
late in December 2005 without hearings and without open
consultation with any medical associations. Although no
Washington group had ever claimed that ultrasound ser-
vices were over-paid, ultrasound was included in the DRA.
The SVS, aided substantially by the Society for Vascular
Ultrasound, mounted a major successful effort for removal
of the physiologic studies such as recording pressures and
bi-directional blood flow from the DRA and prevented
inappropriate loss of tens of millions of dollars per year from
vascular laboratories. SVS lobbying will to continue to push
Congress to refocus the DRA on advanced imaging such as
magnetic resonance imaging and computed tomography
and remove duplex studies from the budget cuts; for exam-
ple, Medicare payments for carotid duplex examinations fell
by almost $82 million dollars per year, and much of that
loss was absorbed by vascular surgeons.
In summary, Congress and key government agencies
including CMS and FDA have recognized that the SVS is
an important advisory on vascular health care issues and will
continue to welcome our input. SVS will continue to
leverage this influence.
ENSURING FUTURE SUCCESS OF SVS
Over the past 5 years since Jack Cronenwett and Tom
Riles orchestrated our merger, the SVS has matured and
now represents the independent specialty of vascular sur-
gery. But it takes more than a statement of goals and a work
plan to be successful. The future success of the SVS and
vascular surgery is certain because the SVS has the follow-
ing internal characteristics and has a successful organiza-
tion.Internal characteristics
SVS members have always been committed, but having
merged together, we now clearly show the following five
characteristics.
Volunteerism. This year, more than 200 members
have volunteered their time to the SVS. I have been im-
pressed how our volunteers have put aside their personal
agendas and dogma in order to work towards improving
our specialty. Our member’s volunteerism in Iraq, is de-
scribed in Ruth Bush’s paper, and is further testament to a
willingness to be involved.
We listen. Communication is a two way process. The
SVS receives input from each of the regional vascular soci-
eties who have a seat on the SVS Board of Directors. In
order to understand the environment and needs of our
members, we welcome input from the Women’s Issues
Committee chaired by Cynthia Shortell, the Diversity
Committee chaired by Chris Kwolek, the recently formed
the Young Surgeons Advisory Group chaired Niten Singh
and the Private Practice Advisory Group chaired by Russell
Samson.
Professionalism. The SVS abides by the core values of
professionalism, commitment, and integrity. As a mature
society, we have a responsibility to uphold these values and
to review complaints against a member related to unprofes-
sional conduct such as false advertising, unscrupulous busi-
ness practices, or fraudulent expert witness testimony. The
Professional Conduct Committee, chaired by Keith Calli-
garo, has reviewed and resolved two such complaints.
Transparency. Transparency in our appointment pro-
cess is now well established. The SVS can no longer be
accused of nepotism. In making appointments to commit-
tees, we announce the vacancies and ask members to
volunteer and submit a short personal statement. Deci-
sions are made by the President, President-Elect, and Vice
President, with input from the Executive Director, and
decisions are based on a balance of the personal statements,
gender, diversity and geography—not favoritism.
Inclusiveness. The SVS is inclusive. The SVS started
as an academic society and indeed still recognizes major
academic contributions of members by appointment to our
category of “Distinguished Fellow of the SVS.” We are
reaching out to welcome all vascular surgeons from within
North America and beyond. This year we have 237 appli-
cations for membership. The International Relations
Committee, chaired by Greg Sicard, awarded five schol-
arships to permit young vascular surgeons from outside
North America to attend our annual meeting and visit
several North American centers. This year, we estab-
lished the first International Chapter of the SVS in India,
and we look forward to the formation of chapters in
China, Brazil, and elsewhere.
Organization is strongThe SVS organization is also strong:
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Becky Maron is outstanding and works collaboratively with
our volunteers.
Budget. We have a suitable operating budget of $5.5
million from royalties from the JVS, contributions from our
corporate partners, and member’s dues. In particular we
acknowledge the support of our platinum corporate
sponsors.
Strategic plans. The strategic plans I described are
feasible. We have well defined plans of action that will
re-establish vascular surgery’s preeminent identity in treat-
ing vascular disease and will make our member’s lives
better.
CONCLUSIONS
I have described the challenges that we will face in the
future. We should be optimistic and see opportunities in
these challenges. I believe that the future of the vascular
surgery is positive.
The face of vascular surgery started changing a decade
ago when SVS leaders recognized the importance of endo-
vascular surgery, emphasized retraining of our members
and changed resident training to include the 0-5 program
so that residents could spend less time in training and focus
on vascular management.
Five years ago, the Society for Vascular Surgery–
American Association for Vascular Surgery merger fur-
ther changed the face of the specialty by allowing vascu-lar surgeons to speak with one voice. Now we have a
logical strategic plan to take us into the future. The three
major goals identified by the SVS Board of Directors are
(1) to promote the independent identity of vascular
surgery, (2) to advance comprehensive vascular care, and
(3) to be the recognized voice for vascular surgeons.
These goals are not merely an intellectual illusion. The
SVS has realistic objectives and action plans to accom-
plish each goal.
Vascular surgery is regaining its independent identity.
We are the only group that can provide comprehensive
vascular patient care. And the SVS will be the recognized
voice for vascular care.
It has been my please to present this “State of the
Society” address on behalf of all the volunteers—past,
present and future—who have developed a mature society
and an independent specialty. These are great times for the
SVS and vascular surgery.
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